ARCHIVES

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

This article is from The Cancer Letter archive.

Vol. 30 No. 19 | May 7, 2004

Download PDF Visit The Full Archive

Related Articles

More Surgical Patients Die When Nurse Caseloads Rise

November 29, 2002

In Brief: Fox Chase Joins Temple Health System, Expands Outpatient and Surgical Services

July 6, 2012

CDC study finds obesity may become leading preventable cause of death; NIH research plan drafted.

March 26, 2004

NCI Forms New Committees to Oversee Cancer Clinical Trials.

February 17, 2006

Biomedical Panel To Hear Public At Sept. Meeting

July 11, 1975

In Brief: Lane Adams Retires, Gadberry New Executive VP; Lemaistre ACS President, Loeb President Elect

November 15, 1985